Primus Pharmaceuticals
As of the edition of 20 October 2026, Primus Pharmaceuticals runs 5 drugs, 3 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 3 |
| Went quiet | 2 |
| Total | 5 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Betamethasone dipropionate | none listed | 3 |
| Clobetasol propionate | none listed | 2 |
| Metaxalone | none listed | 0 |
A route B row is one company at one target.
Where its trials are
- Bones, joints and muscles: 4 trials led
- Skin and connective tissue: 1 trials led